no statement of use filed
on 29 May 2023
Last Applicant/ Owned by
86 Morris Avenue
Summit
NJ
07901
Serial Number
90710082 filed on 13th May 2021
Registration Number
N/A
Correspondent Address
Xiomara Triana
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
Pharmaceutical preparations for human use for the treatment and prevention of obesity, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection, beta thalassemia and myelodysplastic syndromes, myeloprolRead More
Pharmaceutical preparations for human use for the treatment and prevention of obesity, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection, beta thalassemia and myelodysplastic syndromes, myeloproliferative diseases, myelofibrosis, leukemia, lymphoma, multiple myeloma, autoinflammatory disease, blood disease, tumors, multiple sclerosis, ulcerative colitis, arthritis, and musculoskeletal and skin diseases; Pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants, pharmaceutical antibodies, immunotherapies for the treatment of cancer, cytokine inhibitory drugs; Pharmaceutical preparations for human use that modulate the immune system; Pharmaceutical preparations for human use for immunotherapy, namely, T Cell therapy; Pharmaceutical preparations for human use, namely, stem cells for medical or clinical use; Pharmaceutical preparations for human use for treatment or prevention of covid-19, coronavirus disease, and respiratory diseases and disorders; Pharmaceutical preparations for human use, namely, antivirals for treatment or prevention of covid-19, coronavirus disease, and respiratory diseases and disorders; Pharmaceutical preparations for human use, namely, monoclonal antibodies
No 90710082
No Service/Collective Mark
No
No
No
No
No
No
No
No
No
Status Date | Action Taken |
---|---|
29th May 2023 | ABANDONMENT - NO USE STATEMENT FILED |
25th Oct 2022 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
30th Aug 2022 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
30th Aug 2022 | PUBLISHED FOR OPPOSITION |
10th Aug 2022 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
28th Jul 2022 | EXAMINER'S AMENDMENT ENTERED |
28th Jul 2022 | EXAMINERS AMENDMENT -WRITTEN |
28th Jul 2022 | APPROVED FOR PUB - PRINCIPAL REGISTER |
28th Jul 2022 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
28th Jul 2022 | EXAMINERS AMENDMENT E-MAILED |